Skip to main content
Premium Trial:

Request an Annual Quote

Boehringer Ingelheim to Buy ProLink Protein Expression Workcell from Hudson Control Group

NEW YORK, Jan. 16 (GenomeWeb News) - Boehringer Ingelheim Pharmaceutical's research group has bought a protein-expression workcell from Hudson Control Group, Hudson said today.

 

Boehringer will begin using the ProLink in the second quarter to automate such tasks as colony picking, DNA minipreps, and protein purification, said Hudson.

 

Financial details were not released.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.